Seminoma; Embryonal carcinoma; DNA DSBs; Homologous recombination; PARP inhibitors; Deferoxamine; Ferrostatin-1; xCT/SLC7A11 cystine antiporter; Erastin; Targeted therapies; Glutathione. The gene discussed is PARP1; the disease is embryonal carcinoma.